EUVIMEDEUVIMED entdecken
Crossref

NEOSTAR platform trial: neoadjuvant dual immunotherapy plus chemotherapy—more is better?

Shuai Wang, Haiying Cheng

AME Clinical Trials Review · 2024

DOI: 10.21037/actr-23-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2024. Verfasst von Shuai Wang und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wang, S., & Cheng, H. (2024). NEOSTAR platform trial: neoadjuvant dual immunotherapy plus chemotherapy—more is better?. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-26

Vancouver

Wang S, Cheng H. NEOSTAR platform trial: neoadjuvant dual immunotherapy plus chemotherapy—more is better?. AME Clinical Trials Review. 2024. doi:10.21037/actr-23-26

BibTeX
@article{Wang2024,
  author = {Wang, Shuai and Cheng, Haiying},
  title = {NEOSTAR platform trial: neoadjuvant dual immunotherapy plus chemotherapy—more is better?},
  journal = {AME Clinical Trials Review},
  year = {2024},
  doi = {10.21037/actr-23-26}
}
Kostenlos starten →